Literature DB >> 35698079

Correction: Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients.

Yazhen Bi1,2, Zhaohui Wang3, Saran Feng2, Yan Wang2, Yang Zhao4, Hong Li2, Jingyi Yu2, Qian Liu2, Chuansheng Zhu5,6, Mingzhuo Li7.   

Abstract

Entities:  

Year:  2022        PMID: 35698079      PMCID: PMC9190074          DOI: 10.1186/s12885-022-09715-w

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.638


× No keyword cloud information.
Correction: BMC Cancer 22, 477 (2022) https://doi.org/10.1186/s12885-022-09601-5 Following publication of the original article [1], the authors identified the following errors in the article: The color in Fig. 1 was incorrectly marked and has been updated in this correction article.
Fig. 1

Trajectory of PLT counts after induction chemotherapy over time. Each trajectory is represented by a different color. group1: low-stability group, group2: low-level decrease-medium elevation group, group3: low-level decrease-high level elevation group, group4: high-level decrease-medium elevation group

In Table 4, the platelet variables (PLT) in the penultimate line should be in the last line.
Table 4

HRs and 95% CIs of trajectories on mortality risk

ModelaModelbModelcModeld
Trajectories groups
 Group 1ReferenceReferenceReferenceReference
 Group 20.34 (0.16–0.74)†0.32 (0.15–0.68)†0.33 (0.14–0.77)‡0.35 (0.15–0.81)‡
 Group 30.29 (0.14–0.59)*0.31 (0.15–0.63)†0.31 (0.14–0.67)†0.30 (0.14–0.66)†
 Group 40.36 (0.13–0.99)‡0.35 (0.13–0.89)‡0.41 (0.15–1.09)0.27 (0.07–1.09)
 age1.03 (1.01–1.05)†1.03 (1.01–1.05)†1.03 (1.01–1.05)†
 gender0.81 (0.46–1.42)0.68 (0.35–1.29)0.65 (0.33–1.26)
 WBC1.00 (0.99–1.01)1.00 (0.99–1.01)
 Bone marrow blasts2.79 (0.64–12.09)3.06 (0.68–13.74)
 PLT1.00 (0.99–1.01)

HRs hazard ratios, CIs confidence intervals; group 1 to group 4 indicate different trajectories of platelets

aAdjusting for platelet trajectories

bAdjusting for platelet trajectories, age, gender

cAdjusting for platelet trajectories, age, gender, WBC, and bone marrow blasts (bone marrow blasts were damaged, causing 12 to be damaged, leaving 137 people in the model, of whom 87 survived and 50 died)

dAdjusting for platelet trajectories, age, gender, WBC count, bone marrow blasts (bone marrow blasts were damaged, causing 12 to be damaged, leaving 137 people in the model, of whom 87 survived and 50 died.), and PLT

* p<0.001; † p<0.01; ‡ p<0.05

The original article [1] has been corrected. Trajectory of PLT counts after induction chemotherapy over time. Each trajectory is represented by a different color. group1: low-stability group, group2: low-level decrease-medium elevation group, group3: low-level decrease-high level elevation group, group4: high-level decrease-medium elevation group HRs and 95% CIs of trajectories on mortality risk HRs hazard ratios, CIs confidence intervals; group 1 to group 4 indicate different trajectories of platelets aAdjusting for platelet trajectories bAdjusting for platelet trajectories, age, gender cAdjusting for platelet trajectories, age, gender, WBC, and bone marrow blasts (bone marrow blasts were damaged, causing 12 to be damaged, leaving 137 people in the model, of whom 87 survived and 50 died) dAdjusting for platelet trajectories, age, gender, WBC count, bone marrow blasts (bone marrow blasts were damaged, causing 12 to be damaged, leaving 137 people in the model, of whom 87 survived and 50 died.), and PLT * p<0.001; † p<0.01; ‡ p<0.05
  1 in total

1.  Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients.

Authors:  Yazhen Bi; Zhaohui Wang; Saran Feng; Yan Wang; Yang Zhao; Hong Li; Jingyi Yu; Qian Liu; Chuansheng Zhu; Mingzhuo Li
Journal:  BMC Cancer       Date:  2022-05-01       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.